アルテミシニン

アルテミシニン 化学構造式
63968-64-9
CAS番号.
63968-64-9
化学名:
アルテミシニン
别名:
アルテミシニン;(+)-アルテミシニン;アルテアヌイン;(3R,12aR)-3,6α,9β-トリメチル-3β,12α-エポキシ-3,4,5,5aα,6,7,8,8aα,9,10-デカヒドロピラノ[4,3-j]-1,2-ベンゾジオキセピン-10-オン;キンハオス;キングハオス;チンハウサウ;(3R,12aR)-4,5,5aα,6,7,8,8aα,9-オクタヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン;(3R,5aα,8aα,12aR)-デカヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10-オン;キンガオス;アルテアンヌイン;(3R,5aα,8aα,12aR)-4,5,5a,6,7,8,8a,9-オクタヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン;チンハウス;クイングハオス;チンハオス;青蒿素;(αR,1S,3R,5aS,6R,9S,9aR)-α,3,6-トリメチル-1-ヒドロキシ-3,9a-エピジオキシデカヒドロ-2-ベンゾオキセピン-9-酢酸ラクトン;(3R,5aS,6R,8aS,9R,12S,12aR)-4,5,5a,6,7,8,8a,9-オクタヒドロ-3,6,9-トリメチル-3,12-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン;3α,6β,9α-トリメチル-9β,10bβ-エピジオキシ-1,10-ジオキサ-1,2,3β,3aβ,4,5,6,6aβ,7,8,9,10,10aα,10b-テトラデカヒドロシクロヘプタ[de]ナフタレン-2-オン;(αR,1S,5aα)-α,3,6α-トリメチル-1α-ヒドロキシ-3α,9aα-エピジオキシデカヒドロ-2-ベンゾオキセピン-9β-酢酸ラクトン
英語名:
Artemisinin
英語别名:
ARTEMETHER;ARTEANNUIN;ARTEMISIA ANNUA;QINGHAOSU;3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one,octahydro-3,6,9-tri;Astemisinin;huanghuahaosu;Artemisinine,98%;octahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin-10(;(3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epox12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
CBNumber:
CB3387975
化学式:
C15H22O5
分子量:
282.33
MOL File:
63968-64-9.mol

アルテミシニン 物理性質

融点 :
156-157 °C (lit.)
比旋光度 :
76 º (c=0.5,MeOH)
沸点 :
344.94°C (rough estimate)
比重(密度) :
1.0984 (rough estimate)
屈折率 :
75 ° (C=0.5, MeOH)
貯蔵温度 :
-20°C
溶解性:
DMSOに100mM、エタノールに75mMに可溶
外見 :
白色からオフホワイトの結晶性固体。
色:
光学活性 (optical activity):
[α]20/D +76°, c = 0.5 in methanol
Merck :
14,817
安定性::
安定。可燃性。強力な酸化剤、酸、酸塩化物、酸無水物とは相容れない。空気中の二酸化炭素を吸収し、反応する可能性があります。
InChI:
InChI=1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1
InChIKey:
BLUAFEHZUWYNDE-NNWCWBAJSA-N
SMILES:
O1[C@]23[C@@]4([H])O[C@@](C)(CC[C@@]2([H])[C@H](C)CC[C@@]3([H])[C@@H](C)C(=O)O4)O1
LogP:
2.900
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
Sフレーズ  22-24/25
WGK Germany  2
RTECS 番号 KD4170000
HSコード  29322985
毒性 LD50 in mice (mg/kg): 5105 orally; 2800 i.m.; 1558 i.p. (Koch); LD50 in mice, rats (mg/kg): 4228, 5576 orally; 3840, 2571 i.m. (China Cooperative Research Group on Qinghaosu)
絵表示(GHS) GHS hazard pictogramsGHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H242 熱すると火災のおそれ 自己反応性化学品;有機過酸化物 タイプ C, D,タイプ E, F
タイプ G
危険
警告
GHS hazard pictograms P210, P220, P234, P280, P370+P378,P403+P235, P411, P420, P501
H400 水生生物に強い毒性 水生環境有害性、急性毒性 1 警告 GHS hazard pictograms P273, P391, P501
H410 長期的影響により水生生物に非常に強い毒性 水生環境有害性、慢性毒性 1 警告 GHS hazard pictograms P273, P391, P501
注意書き
P210 熱/火花/裸火/高温のもののような着火源から遠ざ けること。-禁煙。
P220 衣類/.../可燃物から遠ざけること。
P234 他の容器に移し替えないこと。
P273 環境への放出を避けること。
P280 保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。
P391 漏出物を回収すること。
P410 日光から遮断すること。
P420 他の物質から離して保管すること。

アルテミシニン 価格 もっと(12)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01CHDASB-00111009 アルテミシニン
Artemisinin
63968-64-9 10mg ¥46400 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01CHDASB-00111009 アルテミシニン
Artemisinin
63968-64-9 100mg ¥300600 2024-03-01 購入
東京化成工業 A2118 アルテミシニン >97.0%(HPLC)
Artemisinin >97.0%(HPLC)
63968-64-9 1g ¥4400 2024-03-01 購入
東京化成工業 A2118 アルテミシニン >97.0%(HPLC)
Artemisinin >97.0%(HPLC)
63968-64-9 5g ¥14000 2024-03-01 購入
関東化学株式会社(KANTO) 49060-52 アルテミシニン
Artemisinin
63968-64-9 25mg ¥47000 2024-03-01 購入

アルテミシニン MSDS


(+)-Arteannuin

アルテミシニン 化学特性,用途語,生産方法

外観

白色~ほとんど白色粉末~結晶

用途

アルテミシニン(Artemisinin、アーテミシニンとも)は、抗マラリア活性を有するセスキテルペンラクトンのひとつで、多薬剤耐性をもつ熱帯熱マラリアにも効果的である。

効能

抗マラリア薬

説明

Artemisinin, a sesquiterpene isolated from a traditional Chinese remedy (quinghao), is useful in the treatment of Fafciparum malaria, including infections caused by chloroquine resistant strains. It is reported to clear parasitemia quicker than i.v. quinine, and is effective in cerebral malaria.

化学的特性

Crystalline Solid

物理的性質

Appearance: colorless needles or white crystalline powder. Solubility: practically insoluble in water, very soluble in dichloromethane, freely soluble in acetone and ethyl acetate, and soluble in glacial acetic acid, methanol, and ethanol. Melting point: 150–153?°C. Specific optical rotation: +75 to +78°.

来歴

The discovery of artemisinin dramatically changes the landscape to combat malaria and leads to a paradigm shift in antimalarial drug development.
However, the discovery of artemisinin is the first stage; the development of artemisinin derivatives and their compound preparations is another important stage. Based on artemisinin, scientists obtained artemisinin ether derivatives by semisynthetic method. After screening of antimalarial activity, artemether was found. To further improve the solubility of artemisinin derivatives, artesunate was also found. The discovery of artesunate makes artemisinin and its derivatives much easier to promote, and more convenient dosage forms to treat malaria enriched the clinic application of artemisinin and its derivatives .

使用

Artemisinin inhibits angiogenesis by down-regulating HIF-1α and VEGF expression in mouse embryonic stem cells. Artemisinin crosses the blood-brain barrier and is an inhibitor of human NOS2 (iNOS).

適応症

Clinically, artemisinin is mainly used to treat malaria symptoms, malignant cerebral malaria, uncomplicated malaria, and severe malaria. Combined with different antimalarial can delay and prevent resistance of malaria parasites. In additional, artemisinin can also be used for systemic lupus erythematosus or discoid lupus erythematosus. Currently, artemisinin derivatives and their compound preparations are widely used in clinic.

定義

ChEBI: A sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.

抗菌性

Artemisinins are active against the erythrocytic and gametocyte stages of chloroquine-sensitive and chloroquine-resistant strains of P. falciparum and other malaria parasites. Two anomers of artemether are produced on synthesis, α-artemether and β-artemether, of which the latter has higher antimalarial activity. Activity against the protozoa Tox. gondii and Leishmania major and the helminth Schistosoma mansoni has been demonstrated in experimental models.

獲得抵抗性

Resistance caused, for example, by changes in the plasmodial endoplasmic reticulum ATPase has been shown in experimental models. There have been clinical reports of reduced susceptibility to treatment with artesunate in Cambodia.

一般的な説明

The artemisinin series are the newest of the antimalarialdrugs and are structurally unique when comparedwith the compounds previously and currently used. Theparent compound, artemisinin, is a natural product extractedfrom the dry leaves of Artemisia Annua (sweetwormwood). The plant has to be grown each year fromseed because mature plants may lack the active drug. The growing conditions are critical to maximize artemisininyield. Thus far, the best yields have been obtained fromplants grown in North Vietnam, Chongqing province inChina, and Tanzania.

応用例(製薬)

Artemisinin (qinghaosu), a compound derived from a plant used in traditional Chinese medicine, Artemisia annua, has been used extensively in East Asia and Africa for the treatment of malaria. This drug, and derivatives that have higher intrinsic antimalarial activity (artesunate, artemether and arteether), have replaced quinine as a treatment of falciparum malaria in many countries, normally in combination with other antimalarials. A semisynthetic derivative, artemisone, which has higher efficacy than artesunate and lower toxicity potential, is in development. Artemisinin and its derivatives also show broad antiprotozoal, anthelmintic and antiviral activities.
The novel structure, containing an endoperoxide bridge, has stimulated the development of semisynthetic and synthetic dioxane, trioxane and tetroxane compounds with activity against Plasmodium spp. and Schistosoma spp. Some of these synthetic trioxalanes are now in clinical development with Medicines for Malaria Venture and other organizations.

生物活性

Antimalarial agent; interacts with heme to produce carbon-centred free radicals, causes protein alkylation and damages parasite microorganelles and membranes. Also selectively inhibits the P-type ATPase (PfATP6) of Plasmodium falciparum (K i ~ 150 nM). Displays antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies.

薬物動態学

Oral absorption: Incomplete
Cmax 500 mg oral: 0.4 mg/L after 1.8 h
Plasma half-life (dihydroartemisinin): 40–60 min
Volume of distribution: c. 0.25 L/kg
Plasma protein binding (artemether): 77%
Artemisinins are concentrated by erythrocytes and are rapidly hydrolyzed to dihydroartemisinin. They are hydroxylated by cytochromes 2B6, 2C19 and 3A4; the derivatives induce this metabolism. After injection, peak plasma concentrations are reached within 1–3 h, when levels of dihydroartemisinin are included. The elimination half-life of intravenous artesunate is <30 min; artemether appears to have a much longer half-life (4–11 h).

薬理学

The mechanism of artemisinins is not known, but the most widely accepted theory is that they are first activated through cleavage after reacting with haem and iron(II) oxide, which results in the generation of free radicals that in turn damage susceptible proteins, resulting in the death of the parasite .
Artemisinin and its derivatives also show a good antitumor effect , which is mainly via (1) apoptosis, ferroptosis, or necrosis; (2) anti-angiogenesis; (3) oxidative stress; (4) tumor suppressor genes; and (5) protein targeting. In addition, artemisinin can exhibit antiarrhythmic, anti-fibrotic, and immunomodulating effects.

臨床応用

Malaria (including cerebral malaria), in combination with other antimalarials.

副作用

A few toxic effects in addition to drug-induced fever and a reversible decrease in reticulocyte counts have been reported. High-dose studies in animal models show neurotoxicity and reproducible dose-related neuropathic lesions; dihydroartemisinin is a toxic metabolite but the precise causes of neurotoxicity are not clear. Embryotoxicity of artemisinin and derivatives has been reported in rodent and primate models, probably due to depletion of erythroblasts.

安全性プロファイル

Moderately toxic by ingestion,intramuscular, and intraperitoneal routes. When heated todecomposition it emits acrid smoke and fumes.

アルテミシニン 上流と下流の製品情報

原材料

準備製品


アルテミシニン 生産企業

Global( 701)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907
qinhe02@xaltbio.com China 1000 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12456 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2503 58
Wuhan Haorong Biotechnology Co.,ltd
+8618565342920
sales@chembj.net China 269 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 994 58
Wuhan Xinhao Biotechnology Co., Ltd
+86-18120578002 +86-18120578002
xinhao-6@xinhaoshengwu.com China 350 58
Sigma Audley
+86-18336680971 +86-18126314766
nova@sh-teruiop.com China 525 58
airuikechemical co., ltd.
+undefined86-15315557071
sales02@airuikechemical.com China 994 58
hebei hongtan Biotechnology Co., Ltd
+86-86-1913198-3935 +8617331935328
sales03@chemcn.cn China 951 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60

アルテミシニン  スペクトルデータ(MS)


63968-64-9(アルテミシニン)キーワード:


  • 63968-64-9
  • artemisiaannual.,extract
  • qinghausau
  • qinghausu
  • QHS
  • ARTEMISININ 99%
  • [3r-(3r,5as,6s,8as,9r,10r,12s,12ar)]-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10-one
  • 3,13-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)one,(ctahydro-3,6,9-trimethyl-,[3R-(3α,5αβ,6β,8αβ,9α,12β,12αR*)]-
  • Arteannuin, Qinghaosu
  • Artemisine,Artemisinin,Arteannuin
  • ARTEMISININ (QINGHAOSU)
  • (+)-Arteannuin
  • 3,12-Epoxy-12H-pyranol(4,3-j)-1,2-benzodioxepin-10(3H)-one, octahydro-3,6,9-trimethyl-, (3- alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12aR*)-(+)
  • Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one
  • (3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3 ,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
  • qinghosu
  • ALPHA BETA ARTEMISININ
  • (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)-methyl
  • ARTEMISINE
  • ARTEMISIA P E
  • ARTEMISININE
  • ARTEMISININ
  • ARTEANUIN
  • SWEET WORMWOOD
  • QINGHAOSA
  • Artemisia annual L Ext.
  • Arteannuin99%
  • Artemesinine98%
  • Quinghaosu
  • ArteMisinin, 98%, froM ArteMisia annua L.
  • ArteMisinin, froM ArteMisia annua
  • アルテミシニン
  • (+)-アルテミシニン
  • アルテアヌイン
  • (3R,12aR)-3,6α,9β-トリメチル-3β,12α-エポキシ-3,4,5,5aα,6,7,8,8aα,9,10-デカヒドロピラノ[4,3-j]-1,2-ベンゾジオキセピン-10-オン
  • キンハオス
  • キングハオス
  • チンハウサウ
  • (3R,12aR)-4,5,5aα,6,7,8,8aα,9-オクタヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン
  • (3R,5aα,8aα,12aR)-デカヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10-オン
  • キンガオス
  • アルテアンヌイン
  • (3R,5aα,8aα,12aR)-4,5,5a,6,7,8,8a,9-オクタヒドロ-3,6α,9β-トリメチル-3β,12α-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン
  • チンハウス
  • クイングハオス
  • チンハオス
  • 青蒿素
  • (αR,1S,3R,5aS,6R,9S,9aR)-α,3,6-トリメチル-1-ヒドロキシ-3,9a-エピジオキシデカヒドロ-2-ベンゾオキセピン-9-酢酸ラクトン
  • (3R,5aS,6R,8aS,9R,12S,12aR)-4,5,5a,6,7,8,8a,9-オクタヒドロ-3,6,9-トリメチル-3,12-エポキシピラノ[4,3-j]-1,2-ベンゾジオキセピン-10(3H)-オン
  • 3α,6β,9α-トリメチル-9β,10bβ-エピジオキシ-1,10-ジオキサ-1,2,3β,3aβ,4,5,6,6aβ,7,8,9,10,10aα,10b-テトラデカヒドロシクロヘプタ[de]ナフタレン-2-オン
  • (αR,1S,5aα)-α,3,6α-トリメチル-1α-ヒドロキシ-3α,9aα-エピジオキシデカヒドロ-2-ベンゾオキセピン-9β-酢酸ラクトン
  • (1R,4S,5R,8S,9R,12S,13R)-1,5,9-トリメチル-11,14,15,16-テトラオキサテトラシクロ[10.3.1.04,13.08,13]ヘキサデカン-10-オン
  • (3R,5aS,6R,8aS,9R,12S,12aR)-3,6,9-トリメチル-3,12-エポキシ-3,4,5,5a,6,7,8,8a,9,10-デカヒドロピラノ[4,3-j]-1,2-ベンゾジオキセピン-10-オン
  • (3R,3aS,6R,6aS,9R,10aS,10bR)-3,6,9-トリメチル-9,10b-エピジオキシ-1,10-ジオキサ-1,2,3,3a,4,5,6,6a,7,8,9,10,10a,10b-テトラデカヒドロシクロヘプタ[de]ナフタレン-2-オン
  • セスキテルペン
  • その他 (試験研究用抗生物質)
  • テルペン
  • 抗生物質
  • 生化学
  • 試験研究用抗菌剤
  • 抗マラリア薬
Copyright 2017 © ChemicalBook. All rights reserved